Travere Therapeutics, Inc. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Travere Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Travere Therapeutics, Inc. for May 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 18.71 | 984 | 18,411 | 26,988 | 28 K to 27 K (-3.52 %) |
May 16 2019 | RTRX | Retrophin, Inc. | McFarlane Neil F. | Chief Operating Off ... | Sell | S | 17.78 | 984 | 17,496 | 27,972 | 29 K to 28 K (-3.40 %) |
May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 18.71 | 1,250 | 23,388 | 13,500 | 14.8 K to 13.5 K (-8.47 %) |
May 16 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Sell | S | 17.78 | 1,250 | 22,225 | 14,750 | 16 K to 14.8 K (-7.81 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.76 | 812 | 14,421 | 18,185 | 19 K to 18.2 K (-4.27 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Sell | S | 17.78 | 813 | 14,455 | 18,997 | 19.8 K to 19 K (-4.10 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.71 | 525 | 9,298 | 19,508 | 20 K to 19.5 K (-2.62 %) |
May 16 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Sell | S | 17.75 | 525 | 9,319 | 20,033 | 20.6 K to 20 K (-2.55 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 17.82 | 1,838 | 32,753 | 255,966 | 257.8 K to 256 K (-0.71 %) |
May 16 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Sell | S | 17.79 | 1,838 | 32,698 | 257,804 | 259.6 K to 257.8 K (-0.71 %) |
May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Option Exercise | A | 17.87 | 14,000 | 250,180 | 14,000 | |
May 15 2019 | RTRX | Retrophin, Inc. | Poole Sandra | Director | Grant | A | 0.00 | 3,500 | 0 | 3,500 | 0 to 3.5 K |
May 10 2019 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Squarer Ron | Director | Grant | A | 0.00 | 2,000 | 0 | 8,875 | 6.9 K to 8.9 K (+29.09 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Orwin John A | Director | Grant | A | 0.00 | 2,000 | 0 | 8,875 | 6.9 K to 8.9 K (+29.09 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Meckler Jeffrey A | Director | Grant | A | 0.00 | 2,000 | 0 | 61,000 | 59 K to 61 K (+3.39 %) |
May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | LYONS GARY A | Director | Grant | A | 0.00 | 2,000 | 0 | 31,000 | 29 K to 31 K (+6.90 %) |
May 10 2019 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,000 | 0 | 29,000 | 27 K to 29 K (+7.41 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Coughlin Timothy P | Director | Grant | A | 0.00 | 2,000 | 0 | 29,000 | 27 K to 29 K (+7.41 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Baynes Roy D. | Director | Grant | A | 0.00 | 2,000 | 0 | 11,000 | 9 K to 11 K (+22.22 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Option Exercise | A | 17.94 | 8,000 | 143,520 | 8,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ASELAGE STEVE | Director | Grant | A | 0.00 | 2,000 | 0 | 259,642 | 257.6 K to 259.6 K (+0.78 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
May 10 2019 | RTRX | Retrophin, Inc. | REED ELIZABETH E | SVP, GC & Corporate ... | Grant | A | 0.00 | 6,000 | 0 | 20,558 | 14.6 K to 20.6 K (+41.21 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 6,000 | 0 | 19,810 | 13.8 K to 19.8 K (+43.45 %) |
May 10 2019 | RTRX | Retrophin, Inc. | ROTE WILLIAM E. | Senior Vice Preside ... | Grant | A | 0.00 | 6,000 | 0 | 19,810 | 13.8 K to 19.8 K (+43.45 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Rosenberg Noah L. | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Option Exercise | A | 17.96 | 40,000 | 718,400 | 40,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Clague Laura | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 |